Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Cancer Lett. Author manuscript; available in PMC 2010 September 8.
Published in final edited form as:
PMCID: PMC2782654

Imidazole Metalloporphyrins as Photosensitizers for Photodynamic Therapy: Role of Molecular Charge, Central Metal and Hydroxyl Radical Production


The in vitro photodynamic therapy activity of four imidazole-substituted metalloporphyrins has been studied using human (HeLa) and mouse (CT26) cancer cell lines: an anionic Zn porphyrin and a homologous series of three cationic Zn, Pd or InCl porphyrins. A dramatic difference in phototoxicity was found: Pd cationic > InCl cationic > Zn cationic > Zn anionic. HeLa cells were more susceptible than CT26 cells. Induction of apoptosis was demonstrated using a fluorescent caspase assay. The anionic Zn porphyrin localized in lysosomes while the cationic Zn porphyrin localized in lysosomes and mitochondria, as assessed by fluorescence microscopy. Studies using fluorescent probes suggested that the cationic Pd porphyrin produced more hydroxyl radicals as the reactive oxygen species. Thus, the cationic Pd porphyrin has high potential as a photosensitizer and gives insights into characteristics for improved molecular designs.

Keywords: structure function relationship, photophysics, phototoxicity, metalloporphyrins, apoptosis, fluorescence microscopy, reactive oxygen species, hydroxyl radicals


Photodynamic therapy (PDT) is an emerging therapy for many diseases including cancer, neovascular and hyperproliferative disorders and infections. The therapy relies on the triple interaction between a non-toxic photosensitizer (PS) or dye molecule, harmless visible light of an appropriate wavelength to be absorbed by the PS, and molecular oxygen [1]. Following the absorption of light (photons), one of the electrons of the ground state PS is boosted into a higher-energy orbital to form the first excited singlet state. This is a short-lived (nanoseconds) species that can lose its energy by emitting light (fluorescence) or by internal conversion into heat. The excited singlet state PS may also undergo the process known as intersystem crossing whereby the spin of the excited electron inverts to form the relatively long-lived (microseconds to milliseconds) excited triplet-state that has electron spins parallel. The PS excited triplet can undergo three broad kinds of reactions that are usually known as Type I and Type II. In a Type I reaction, the triplet PS can gain or donate an electron from a neighboring molecule. In a Type II reaction, the triplet PS can transfer its energy directly to molecular oxygen (ground state triplet) to form reactive singlet oxygen [2].

Many of the traditional PS that have been used clinically are based on the porphyrin or tetrapyrrole nucleus found in such preparations as hematoporphyrin derivative [3]. There is a considerable amount of interest in designing and synthesizing new PS including porphyrinoid structures, with improved characteristics for investigation as possible new PDT drugs [4, 5]. These desired improved properties include: being pure characterizable compounds, having large absorption peaks in the red and near-infrared regions of the electromagnetic spectrum, and having high uptake in cancer or other pathogenic cells [6]. For PS designed to kill cancer or other mammalian cells, it has been found that the intracellular localization of the PS is another important parameter, with PS that localize in mitochondria tending to be more powerful in killing cells than those PS that are found in other locations such as lysosomes [7].

The molecular characteristics of the PS such as charge, lipophilicity and asymmetry govern the localization and uptake of the compounds by various cell types, and also determine the pharmacokinetics, biodistribution and localization of the PS at the target site. Photosensitizers with constitutive cationic charges such as quaternary ammonium groups have been shown to be highly effective PS both against cancer cells [8] and against microorganisms [9] compared to negatively charged, neutral, or even basic-amino groups.

A range of seemingly disparate tetrapyrrole structures containing metal chelates have been investigated as PS in clinical and pre-clinical PDT applications. Zinc(II) and aluminum(III) phthalocyanines have been studied as both unsubstituted compounds [10] and with varying numbers of sulfonate groups attached to the benzo substituents [11]. Silicon(IV) is chelated in the phthalocyanine known as PC4 [12]. Tin(II) is chelated into an etiopurpurin (SnET2) otherwise known as Purlytin [13]. Indium(III) is present in a chelate of pyropheophorbide methyl ester known as MV6401 [14]. The rare earth metal lutetium(III) is chelated into the novel macrocycle known as texaphyrin to produce motexafin lutetium [15]. Palladium(II) is chelated into two bacteriochlorin compounds, bacteriopheophorbide (TOOKAD or WST-09) [16] and its taurine derivative (Stakel or WST-11) [17], which have been used for vascular targeted PDT.

In this report we studied a set of four hydrophilic porphyrins: a zinc porphyrin bearing a net negative charge on the imidazole-bearing peripheral substituent and a homologous set of net positively charged imidazolium-substituted porphyrins that contain central zinc(II), palladium(II), and indium(III) metal ions [18]. The four porphyrins are shown in Figure 1. These porphyrins were chosen as model structures to study relationships between the charge and metal substituent, since porphyrin based photosensitizers are the most widely studied compounds in PDT and hematoporphyrin derivative and protoporphyrin IX are the two most broadly used photosensitizers in the clinical setting. The rationale to choose the imidazole pendant groups was as a means of varying the overall charge without a dramatic change to the structure. Dramatic differences were observed in the effectiveness of the compounds as PS against mouse and human cancer cells, and these differences depended on the charge, central metal atom, and production of hydroxyl radicals as the reactive oxygen species (ROS).

Figure 1
Synthetic scheme and chemical structures.


Synthesis of Imidazole Porphyrins

General Procedures

Absorption spectra and fluorescence spectra were collected at room temperature. Porphyrins were analyzed in neat form by laser desorption mass spectrometry (LD-MS) [19] and by matrix-assisted laser-desorption ionization mass spectrometry (MALDI-MS) using the matrix 4-hydroxy-α-cyanocinnamic acid. In both LD-MS and MALDI-MS analyses, positive ions were detected. Solvents were dried according to standard procedures. All chemicals were used as received from commercial sources.

5-(1,3-Diethylimidazol-2-ium)-10-phenylporphinatoindium(III) chloride (2-InCl)

Following a general procedure [20] porphyrin 3-Zn [18] (23 mg, 0.035 mmol) in ethanol (EtOH) (7 mL) was treated with concentrated aqueous HCl (7 mL). The resulting mixture was refluxed for 21 h under argon. The reaction mixture was then cooled to room temperature, whereupon the volatile solvent was removed. The resulting suspension was poured into a large volume of ethyl acetate and water. Saturated aqueous NaHCO3 solution was added slowly to the aqueous-organic mixture. The organic layer was separated, and the aqueous layer was extracted twice with ethyl acetate. The combined organic extract was washed with saturated aqueous NH4Cl solution and water. The organic layer was separated, dried (Na2SO4) and concentrated to give free base porphyrin 4 as a dark purple solid. Data for 4: LD-MS obsd 452.2, calcd 452.2 (C29H20N6); λabs (methanol, (MeOH)) 402, 500, 534, 574, nm; λem (MeOH) 625, 700 nm. A solution of porphyrin 4 (~0.035 mmol) in anhydrous DMF (7 mL) was treated with InCl3 (0.30 g, 1.4 mmol). The reaction mixture was heated to reflux for 40 h under argon. The crude reaction mixture was concentrated. The residue was chromatographed [silica, CH2Cl2/MeOH in a gradient of (9:1) to (4:1)] to afford porphyrin 4-InCl as a green solid. Data for 4-InCl: MALDI-MS 595.8; λabs (MeOH) 410, 598 nm; λem (MeOH) 620 nm. The entire sample of 4-InCl (~0.035 mmol) was treated with EtI (0.28 mL, 3.5 mmol) in DMF (2.0 mL), and the resulting mixture was heated at 65 °C for 3 days. The reaction mixture was then concentrated and chromatographed twice [(1) silica, CH2Cl2/MeOH (9:1); (2) neutral alumina, CH2Cl2 An external file that holds a picture, illustration, etc.
Object name is nihms100789ig1.jpg CH2Cl2/MeOH (9:1)] to afford a solid residue. The solid residue was purified by preparative size-exclusion chromatography (3 × 30 cm) eluted with HPLC-grade tetrahydrofuran (THF). A final chromatographic procedure [alumina, CH2Cl2/MeOH in a gradient of (9:1) to (3:1)] afforded the title compound as a dark green solid (9.0 mg, 33% overall yield, assuming an iodide counterion): MALDI-MS obsd 656.8, calcd 657.1 (C33H27ClInN6, lacking a counterion); λabs (MeOH) 411, 601 nm; λem (MeOH) 620, 670 nm.


The absorbance and fluorescence spectra, fluorescence quantum yields and excited-state singlet lifetime measurements of 1-Zn, 2-Zn, 2-Pd, and 2-InCl were investigated at room temperature in a 3:1 mixture of THF and MeOH. The lifetimes of the lowest energy triplet excited state were measured at room temperature and at 77 K on compounds in ethanol. Details of the measurements, including determination of molar absorption coefficients utilized herein to prepare solutions of known concentration, are given elsewhere [26].

Cell Culture

HeLa (human cervical squamous carcinoma cells) [21], and CT26 (murine colon adenocarcinoma) [22] were obtained from ATCC (Manassas, VA) and cultured in RPMI1600 medium (Gibco Invitrogen, Carlsbad, CA) with L-glutamine and NaHCO3 supplemented with heat inactivated fetal bovine serum 10% (vol/vol), penicillin (100 U/mL) and streptomycin (100 µg/mL) (all from Sigma, St Louis, MO) at 37 °C in 5% CO2 humidified atmosphere in 75 cm2 flasks (BD Falcon, San Jose, CA). When the cells reached 80% confluence, they were washed with PBS (Sigma) and harvested with 2 mL of 0.25% Trypsin-EDTA solution (Sigma). Cells were centrifuged and counted in trypan blue (Sigma) and plated at 5000 cells/well in flat-bottomed 96 well plates (Fisher). Cells were allowed to attach for 24 h.

Light Source

Illumination of cells utilized a non-coherent white light source (Lumacare, Newport Beach, CA) fitted with a light guide containing a band pass filter (λ400–700 nm) adjusted to give a uniform spot of 4 cm in diameter with an irradiance of 100 mW/cm2 as measured with a power meter (model DMM 199 with 201 Standard head, Coherent, Santa Clara, CA). For the experiments assessing the production of intracellular ROS we used 405 nm laser light (Nichia Corp, Detroit, MI).

PDT Experiments

The PS were dissolved in DMSO at a concentration of 5 mM and stored in the dark at room temperature. PS were added at different concentrations to cells in fresh complete medium for 24 h incubation periods. The DMSO concentration in the medium was less than 0.5%. After incubation the medium was replaced with 200 µL of fresh medium and PDT with white light was performed. For experiments where the light dose was varied, fluences of 0 (dark toxicity), 2, 4, 8, 10, 12, 16, and 20 J/cm2 were used, and 9 wells (one group) were illuminated at one time. Controls were cells with no treatment and cells with light alone at the highest fluence. For experiments where the porphyrin concentration was varied (concentrations between 100 nm and 24 µM) a fixed fluence of 10 J/cm2 delivered at the same irradiance was used. Here additional groups of cells were incubated with all the concentrations of porphyrins but no illumination was used to determine the dark toxicity of the PS. At the completion of the illumination the plates were returned to the incubator for a further 24 h, before further studies. We used a MTT colorimetric assay (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) a tetrazolium salt that measures mitochondrial reductase activity and correlates well with colony-forming assays as a measure of cell viability, as has been described previously [2326]. The absorbance for MTT assay was read at 560nm.

Photosensitizer Uptake

5×103 HeLa cells were plated per well in a 96 well plate and allowed overnight to attach. The next day 2-Zn, 1-Zn or 2-Pd was added and incubated for 24 h. After incubation, the medium was removed and 200 µL of 1M NaOH/1%SDS was added and cells were incubated overnight. The fluorescence (2-Zn and 1-Zn) was measured using excitation at 402 nm and detection at 641 nm with a plate-reader (Molecular Devices, Sunnyvale CA), while the absorption was measured at the Soret maximum (λ402 nm). Unfortunately the 2-Pd compound is non-fluorescent therefore the uptake had to be measured by the means of absorption. The protein per sample was measured with bicinchoninic acid protein assay [27]. Fluorescence (for 1-Zn and 2-Zn) and absorption standard curves (for 1-Zn, 2-Zn and 2-Pd) were prepared by adding known amounts of 2-Zn, 1-Zn or 2-Pd solutions to pre-prepared cell lysates in NaOH/SDS and incubated for 24 h. On the following day the fluorescence and absorption was measured as described above.

Apoptosis Assay

The induction of apoptosis by imidazole-porphyrin mediated PDT was measured by a fluorescence assay using Ac-DEVD-AFC (BD Pharmingen, San Jose, CA), a caspase fluorescent substrate [28]. The results were normalized to the content of protein in the sample. Briefly HeLa cells were treated with PDT sufficient to kill 80% of the cells. Following PDT, samples were collected at 2, 4, 6, 12, and 24 h and centrifuged. The pellet was resuspended in 100 µL of lysis buffer [29] containing protease inhibitor and subjected to 3–4 cycles of freezing and thawing. Then 50 µL of each sample was transferred to separate wells and 50 µL of 2X reaction buffer was added together with Ac-DEVD-AFC (final concentration 50 µM). Samples were incubated in the dark for 1 h at 37 °C, and fluorescence was measured in a plate reader (λex 400 nm, λem 505 nm). The protein per sample was measured with bicinchoninic acid protein assay.

Fluorescence Microscopy – Intracellular Localization

5×105 HeLa cells were plated on 35mm dishes and allowed overnight to attach. The next day 5 µM 2-Zn or 1-Zn in culture medium was added and incubated for 24 h. Cells were washed in PBS and 5 µg/mL of lysotracker or mitotracker (LysoTracker Green DND-26, MitoTracker Green FM, Molecular Probes Invitrogen) was added and incubated for 30 min at 37 °C. Cells were again washed in PBS and 5–10 min later a Leica DMR confocal laser fluorescence microscope (Leica Mikroskopie und Systeme GmbH, Wetzler, Germany) with excitation by a λ488 nm argon laser and emission with either a λ525 nm +/− 10-nm bandpass filter, or a λ580-nm longpass filter and a 63×1.20 NA water immersion lens was used to image the cells at a resolution of 1024×1024 pixels. Images were acquired using TCS NT software (Version 1.6.551, Leica Lasertechnik, Heidelberg, Germany). The intracellular localization of 2-Pd compound by confocal microscopy could not be identified due to the lack of fluorescence of this compound.

Detection of photodamage by fluorescent probes

We used the fluorescent probes, acridine orange (AO) and rhodamine 123 (Rho 123) (both from Sigma, St Louis, MO) to detect the location of PDT associated intracellular damage. 5×105 HeLa cells were plated on 35mm dishes and allowed overnight to attach. The next day 5 µM 2-Zn or 0.5 µM 2-Pd in culture medium was added and incubated for 24 h. Cells were washed in PBS and 5 J/cm2 of white light was delivered. Immediately after PDT 0.5 µM of AO or 0.5 µM Rho 123 was added to the cells and incubated for 5 min in complete medium at 37 °C. Next the cells were washed and the intracellular localization of the dye was observed by confocal microscopy. Both probes were excited with Ar-laser 488-nm and emission wavelengths were AO (green fluorescence 525 nm +/− 10-nm, or red fluorescence 580-nm longpass) and Rho 123 (525 nm +/− 10-nm) [30]. As controls we used HeLa cells that were incubated with either AO or Rho 123 but did not receive PDT.

Intracellular ROS

HeLa cells were incubated with 5 µM 2-Zn, 1-Zn or 2-Pd for 24 h, and on the next day 5 µg/mL of 5-(and-6)-chloromethyl-2'7'-dichlorodihydrofluorescein diacetate acetyl ester (CM-H2DCFDA, Molecular Probes Invitrogen) in complete medium was added and incubated for 30 min at 37 °C. Cells were then washed with PBS, and 5 J/cm2 of 405 nm laser light (Nichia Corp, Detroit, MI) was delivered. Blue light was used to minimize the photoactivation of dichlorodihydrofluorescein by small amounts of contaminating dichlorofluorescein that has been shown to be able to act as a PS when green light is used [31]. In similar experiments, 10 µM of 3`-(4-hydroxyphenyl)fluorescein (HPF, Molecular Probes Invitrogen) was added and incubated for 1 h in complete medium at 37 °C. After the incubation, the cells were washed with PBS and 5 J/cm2 of white light was delivered. The cells were imaged immediately after PDT with the confocal microscope (488-nm excitation, 530-nm detection).

Cell-free experiments were also performed with HPF in 96 well plates. The dyes were aliquoted at the final concentration of 5 µM per well in PBS, and HPF was added to each well at the final concentration of 10 µM. Four wells formed one experimental group. For hydroxyl radical quenching experiments 100 mM mannitol was added. All groups were illuminated simultaneously and white light was delivered in sequential doses of 5 J/cm2. After each dose the fluorescence was measured by fluorescence plate reader (488-nm excitation, 520-nm detection).


Preparation of Porphyrins

The four porphyrins examined in this study are shown in Figure 1. Each porphyrin is of the trans-AB-type wherein a phenyl group is located at one meso-position, an imidazolium substituent is located at the trans meso-position, and the flanking meso-positions lack substituents. Porphyrins 1-Zn and 2-Zn are zinc(II) chelates, whereas 2-InCl is a chloro-indium(III) chelate, and 2-Pd is a palladium(II) chelate. The imidazolium group in each porphyrin is dialkylated. In porphyrin 1-Zn, the alkyl groups are 4-sulfobutyl units, whereas ethyl groups are present in porphyrins derived from 2. The synthesis of porphyrins 1-Zn, 2-Zn, and 2-Pd has been reported [18]. Porphyrin 2-InCl was prepared as follows (Figure 1). Known porphyrin [18] 3-Zn was treated with conc. aqueous HCl in refluxing EtOH [20] to afford the free-base porphyrin 4 that lacks the 2-trimethylsilylethoxymethyl protecting group. Refluxing a mixture of porphyrin 4 and InCl3 in DMF for 40 h afforded indium-chelated porphyrin 4-InCl. Porphyrin 4-InCl was heated with EtI in DMF at 65 °C for 3 days, whereupon diethyl imidazolium–porphyrin 2-InCl was obtained as a green solid. The overall yield for the three steps starting from the porphyrin 3-Zn to the resulting indium imidazolium–porphyrin 2-InCl was 33% (assuming an iodide counterion).


The photophysical properties of the four porphyrins in a number of media and at room temperature and 77 K have been characterized separately [32]. Salient characteristics are summarized in Table 1. Figure 2 shows optical spectra of the compounds in tetrahydrofuran/methanol, where aggregation is minimal. The fluorescence follow the same trends as the lifetimes of the lowest energy singlet excited state (S1) in the order 2-Pd < 2-InCl < 1-Zn ~ 2-Zn. These trends reflect a progressive increase in the yield of intersystem crossing from S1 to the lowest energy triplet excited state (T1): 2-Pd (>0.99) > 2-InCl (0.98) > 2-Zn (0.80) ~ 1-Zn (0.80). The T1 lifetime is much shorter for 2-Pd (10 µs, 295 K; 2 ms, 77 K) than for 1-Zn and 2-Zn (~5 ms, 295 K; ~60 ms, 77 K), which reflects in part a ~1000-fold greater radiative (phosphorescence) rate constant for 2-Pd. The T1 lifetimes are considerably reduced in air-saturated solutions at 295 K (e.g., 300 ns for 2-Pd) and give rate constants for quenching by O2 (e.g., 1.7 × 109 M−1s−1 for 2-Pd) that are comparable to those for a variety of porphyrins [33]. These values indicate that the quenching process for each porphyrin in air-saturated solution occurs near the diffusion limit (for triplet-triplet energy transfer) and is basically quantitative (because of a sufficient number of effective collisions), despite the much shorter T1 lifetime for 2-Pd compared to the other sensitizers.

Figure 2
Absorption spectra (A) and fluorescence spectra (B) for porphyrin sensitizers in air-saturated tetrahydrofuran/methanol (3/1) at 295 K.
Table 1
Photophysical Data.a

PDT experiments

We initially used a concentration of 5 µM of the compounds 1-Zn and 2-Zn incubated with cells for 24 h and illuminated with broadband white light. Figure 3A depicts the light-dose dependent loss of mitochondrial activity in the two cell lines for 1-Zn, and Figure 3B shows the phototoxic dose response with 2-Zn. In both cell lines 2-Zn (Figure 3B) was highly effective at inactivating mitochondria of cancer cells, while 1-Zn had no effect (Figure 3A). In the case of the human HeLa cells (Figure 3B) 5 µM of 2-Zn and 20 J/cm2 killed 95% of the cells (almost reaching the level of detection of the assay), while HeLa cells were completely unharmed after 5 µM of 1-Zn and 20 J/cm2. The mouse colon carcinoma line CT26 was less sensitive to 2-Zn-mediated PDT than HeLa cells. In case of 2-Pd, the preliminary experiments suggested that 5 µM concentration is too high for use in the fluence response experiments, since even a very low fluence resulted in 100% cytotoxicity. Therefore in the subsequent experiments, we progressively reduced the concentration of 2-Pd in the incubation until the value of 0.5 µM was reached. Figure 3C demonstrates a good light-dose dependent inactivation of mitochondria relationship with both cell lines, and that HeLa cells are significantly more sensitive than are CT26.

Figure 3
Broad-band white light-fluence dependent inactivation of mitochondria of HeLa cervical cancer and murine CT26 colon adenocarcinoma cells in culture. (A) 1-Zn at 5 µM; (B) 2-Zn at 5 µM; (C) 2-Pd at 0.5 µM. Concentration dependent ...

Because PDT-mediated inactivation of mitochondria was not observed in any cell line using 1-Zn as a PS at 5 µM, we decided to use an increasing range of concentrations of all the PS and deliver only one constant fluence of white light (10 J/cm2) in order to be able to derive meaningful comparisons of the effectiveness of the different compounds as PS. Because PS may exhibit some dark toxicity when used at high concentrations, a dark control was used for each data point. Dark toxicity was negligible (greater than 85% survival at the highest porphyrin concentration (data not shown for clarity). Figure 3A and 3B show the PS dose-dependent inactivation of mitochondria of the four compounds (the InCl compound 2-InCl was by this time available) for both cell lines. The data are best presented in double-log plots because both the percentage of inactivated mitochondria and the concentrations used spanned a large range of values. As expected from the previous experiment, 2-Pd was highly phototoxic to both cell lines with measurable inactivation of mitochondria being observed at concentrations as low as 100 nM and maximal effect reached at 500 nM. Next in the order of effectiveness was 2-InCl where concentrations between 250 nM and 1 µM showed a dose-dependent phototoxicity in both cell lines with the HeLa cells again being more susceptible. The cationic porphyrin 2-Zn was effective at concentrations between 2 and 10 µM, while the anionic compound 1-Zn did show some phototoxicity when used at concentrations between 10 and 50 µM.

Based on the presented results we compared the relative phototoxicity of three porphyrins in HeLa cells on a photon absorbed per cell killed basis (Table 2). The relative effectiveness as a function of photon absorbed by killed cell was calculated by dividing 1/LD50 by (integrated absorbance × relative uptake). The relative phototoxicity of 2-Pd compound was almost 25 times higher compared to 2-Zn compound and over 78 times higher in comparison to 1-Zn compound. There was only a small difference between 1-Zn and 2-Zn compounds in relative effectiveness (3 times).

Table 2
Comparison of relative phototoxicity of three porphyrins in HeLa cells on a photon absorbed per cell killed basis

Although an incubation time of 24 h was used throughout these experiments, it was not clear that this length of incubation time was necessary. In addition, differences in the rate of uptake might provide insight into the wide difference in activity between 2-Zn and 2-Pd. Therefore for 2-Zn and 2-Pd in HeLa cells we used a single concentration of 5 µM for 2-Zn and 500 nM for 2-Pd, together with a single fluence of 10 J/cm2 of white light and varied the incubation time. As can be seen in Figure 4A, there was increasing cell death measured as a function of mitochondria inactivation with increasing incubation time up to 6 h, but no further increase between 6 and 24 h incubation time. Interestingly the porphyrin 2-Pd led to phototoxicity at an earlier time point than homologous compound 2-Zn.

Figure 4
(A) Effect of varying the incubation time on PDT inactivation of mitochondria of HeLa cells mediated by 5 uM 2-Zn or 0.5 µM 2-Pd and 10 J/cm2 of white light. Regardless of incubation time cells were incubated for 24 h before MTT assay. (B) Time ...

We sought to understand whether differences in the effectiveness of the 2-Zn and 2-Pd compounds could be related to the induction of apoptosis after illumination. It is known that many PS cause the death of cancer cells upon illumination by initiating the process of apoptosis via pathways involving mitochondrial damage leading to cytochrome c release, caspase activation and nuclear fragmentation. Figure 4B shows that indeed both 2-Zn and 2-Pd did cause caspase activation and that the peak of caspase activity occurs earlier with 2-Pd than with 2-Zn. The peak value is similar for both PS and it was concluded that differences in mode of cell death did not account for the large difference in phototoxicity.

Photosensitizer Uptake Experiments

Traditionally the cell uptake of PS is measured by extraction of cells after incubation with PS and quantification of the dissolved PS in the cell extract by fluorescence spectrophotometry. In the case of these four compounds, porphyrins 2-Zn and 1-Zn had the expected fluorescence consistent with their structure, while 2-InCl had very low fluorescence and 2-Pd had no detectable fluorescence due to high intersystem crossing rates. We compared the uptake of 2-Zn and 1-Zn with increasing concentration in the incubation medium by fluorescence extraction in HeLa cell line. There was a dose dependent increase in cell uptake for both PS as seen in Figure 4C. The uptake of 1-Zn was lower than that seen for 2-Zn, but did not appear to be as low as might be expected from the lack of phototoxicity observed with 1-Zn at these concentrations. This observation suggests that 2-Zn is a more efficient PS on a molecule per cell basis than is 1-Zn.

Since 2-Pd is essentially non-fluorescent, we used the absorption of cell extracts to measure the uptake. To determine the validity of this measurement we calculated the correlation (r2=0.995, p<0.0001) between the uptake values measured by fluorescence and by absorption for 1-Zn and 2-Zn. Figure 4D shows that the relationship of the uptakes measured by absorption and fluorescence (Figure 4C) for 1-Zn and 2-Zn were the same. We concluded that the absorption assay was reliable and could be used to determine the uptake of non-fluorescent 2-Pd. As can be seen in Figure 4D, there was no significant difference between the cell uptakes of 2-Zn and 2-Pd suggesting that the large differences in phototoxicity seen for the two porphyrins were not due to differences in uptake.

Fluorescence microscopy

Because the zinc porphyrins had sufficient detectable fluorescence we were able to carry out confocal microscopy experiments to determine their intracellular localization with the use of green fluorescent intracellular tracers for lysosomes and mitochondria. The anionic 1-Zn localizes mainly in lysosomes as can be seen from Figure 5; substantial overlap exists between the red porphyrin fluorescence and the green lysotracker fluorescence (Figure 5A) while no overlap is seen with red porphyrin fluorescence and green mitotracker fluorescence (Figure 5B). By contrast the cationic 2-Zn shows overlap with both green lysotracker (Figure 5C) and with green mitotracker (Figure 5D), indicating that its localization is more mitochondrial than that of 1-Zn. However in case of 2-Zn we observed a “patchy” accumulation of the dye in the mitochondria. In some cells a perfect overlap was observed and in the others only minimal accumulation of the dye was seen. Figure S1 presents additional fields of view that provide additional evidence for “patchy” distribution of 2-Zn dye.

Figure 5
Fluorescence micrographs of Hela cells showing red fluorescence from 1-Zn (A and B) and 2-Zn (C and D) overlaid with green fluorescence from lysotracker (A and C) and from mitotracker (B and D). Scale bar is 25 µm.

Detection of photodamage by fluorescent probes

Because 2-Pd compound does not have any measurable fluorescence we could not image its intracellular localization directly. However, we employed the fluorescent probes, such as acridine orange (AO) that labels lysosomes and rhodamine 123 (Rho 123) that labels mitochondria [34], to determine the location of intracellular damage caused by PDT with 2-Pd and for comparison by PDT with 2-Zn. AO has been shown to emit two colors of fluorescence; a red fluorescence that is typical of aggregated dye in lysosomes and a green fluorescence typical of the disaggregated dye when bound to nucleic acids such as nuclear DNA [35]. The typical labeling patterns for AO and Rho 123 for control, non-treated HeLa cells and cells that received PDT mediated by 2-Zn and 2-Pd are shown in figure 6. After delivering 5J/cm2 of white light we observed significant change in the pattern of probe accumulation. Instead of well demarcated lysosomes containing AO we observed dispersed fluorescence throughout the cells, with significant translocation of the AO to the nucleus (probably in nuclosomes), where upon binding to DNA it also produced green fluorescence. The nuclear relocalization was more pronounced in the case of 2-Pd compared to 2-Zn where the overall PDT damage was also more severe (see the presence of many extracellular blebs). The characteristic structure of mitochondria outlined by accumulation of Rho 123 in control HeLa cells was even more dramatically altered by PDT damage. We observed strong green fluorescence throughout the cells after PDT treatment suggesting the disruption of mitochondria and relocalization of the probe. Interestingly Rho123 also appeared to have relocated into nucleosomes after mitochondrial damage as might be expected of a lipophilic cationic dye. Both 2-Zn and 2-Pd damaged both lysosomes and mitochondria, but it may be that the relative damage to mitochondria was more pronounced for 2-Pd compared to 2-Zn. These results support our hypothesis that the one of the factors that is responsible for better PDT effect of 2-Pd over 2-Zn is preferential localization and damage to mitochondria than lysosomes.

Figure 6
Fluorescence micrographs of HeLa cells incubated with 5 µM 2-Zn or 0.5 µM 2-Pd and either 0.5 µM of Acridine orange or 0.5 µM Rhodamine 123. Cells were either illuminated or not with 5 J/cm2 of white light. Bar is 10 µm. ...

Intracellular ROS

We first used the probe dichlorodihydrofluorescein (DCDHF) for intracellular ROS. This probe is fluorescence activated by many different ROS such as hydrogen peroxide, hydroxyl radicals, and by organic peroxides that are formed by reaction between unsaturated lipids and singlet oxygen. All three tested porphyrins (2-Pd, 2-Zn, 1-Zn) produced increased DCDHF fluorescence after illumination with 5 J/cm2 of blue light (Figure 6) in the order 2-Pd > 2-Zn > 1-Zn; however, the difference between the three compounds did not appear to be sufficient to explain the observed differences in phototoxicity. We then asked whether the new specific fluorescence probe for hydroxyl radicals, HPF [36] might show a major difference between the three porphyrins. As is shown in Figure 6A, there was only significant intracellular fluorescence generated in HeLa cells after white light illumination in the case of 2-Pd, while 2-Zn and 1-Zn did not show a HPF fluorescence increase. In supplementary Figure S2 we show an appropriate set of controls to demonstrate that neither DCDHF or HPF was alone activated by the light used for the porphyrin [31], and that none of the three porphyrins exhibited fluorescence in the green region of the spectrum. In the supplementary Figure S3 we also present micrographs of HeLa cells that were incubated with 50uM concentration of 2-Zn and 10uM HPF. The results show that even at 10 times higher concentration the production of hydroxyl radicals by 2-Zn PDT was minimal.

To confirm the hypothesis that illumination of 2-Pd produced hydroxyl radicals, we repeated the experiments with cell-free solutions of the three porphyrins in PBS (Figure 6B, C and D). There was a light-dose dependent increase in HPF fluorescence from 2-Pd that was significantly greater than that seen in the case of 2-Zn and 1-Zn. Moreover, the light-dependent increase in fluorescence from 2-Pd and HPF was significantly quenched by 100 mM mannitol. Mannitol is well known as a quencher of hydroxyl radicals [37, 38]. Interestingly the increase in HPF fluorescence was greater in the case of the cationic 2-Zn than it was for the anionic 1-Zn (although much less than that for 2-Pd). The proportion of HPF fluorescence increase that was quenched by mannitol was comparable (about 50%) for all three porphyrins.


This report has found a novel structure-function relationship among PDT agents consisting of cationic imidazolium porphyrins with different central metal ions (2-Pd > 2 InCl > 2 Zn). As calculated in Table 2 the relative effectiveness on a photon absorbed per cell killed basis was that 2-Pd was twenty-five times more effective than 2-Zn. There have only been a few reports of structure-function relationships for porphyrinic compounds with different central metal substituents where the function of interest is PDT effectiveness as PS against cancer cells in vitro. Milanesio et al [39] compared a series of meso-tetrakis(4-methoxyphenyl)porphyrins with different central metals and found the order of activity was Cd = Zn > free base > Cu. Kolarova et al [40] studied meso-tetrakis(sulfonatophenyl)porphyrin and found that the order of phototoxicity was Zn > Pd > free base. Rosenfeld et al [41] compared a series of ether derivatives of pyropheophorbide a containing different metals and found the order of effectiveness was InCl > Zn > free base > Cu.

As expected the cationic Zn porphyrin 2-Zn was a much better PS that the anionic Zn porphyrin 1-Zn. The uptake experiments (both fluorescence and absorption) confirmed that the cationic porphyrin was taken up 4–5 times more readily than the anionic porphyrin. Cationic dyes are thought to be more easily taken up into cells by virtue of better binding to the anionic plasma membrane and therefore more likely to be internalized by endocytotic processes than anionic dyes that do not readily bind to the membrane [42]. Although lipophilic PS also show high uptake into cells, probably by diffusing through lipid bilayer membranes, they are not usually water soluble and require some delivery system such as liposomes, micelles or emulsions to deliver them into cells [43]. The cationic Pd porphyrin 2-Pd showed the same uptake by the cells as the cationic Zn porphyrin 2-Zn, and suggested that replacing the divalent zinc ion with the larger but still divalent palladium ion did not make any significant difference to the lipophilicity of the molecule, or to the overall charge on the imidazolium-bearing peripheral substituent. The cationic 2-Zn was localized in both mitochondria and in lysosomes, while the anionic 1-Zn was confined to lysosomes. The explanation for this observation lies in the difference in log P values (0.59 for 1-Zn compared to 3.1 for 2-Zn) since more hydrophilic PS tend to concentrate in lysosomes and more lipophilic PS concentrate in membrane-rich organelles such as mitochondria and endoplasmic reticulum [44]. Furthermore the net positive charge on 2-Zn is also likely to encourage the accumulation in mitochondria due to the well known mitochondrial targeting properties of lipophilic cations [45]. There is a substantial body of knowledge on the PDT effect of different sub-cellular localizations of various porphyrins and related compounds such as phthalocyanines. PS that localize in mitochondria are known to be much more phototoxic than PS that localize in lysosomes [46]. Since the three cationic imidazolium porphyrins (2-Zn, 2-InCl, 2-Pd) differ only in the central metal ion and otherwise are expected to have very similar structures, the only molecular characteristic that potentially could cause differences in subcellular localization is the different axial-ligation behavior of the three metal ions [47]; thus other explanations for the large difference in phototoxicity must exist. The experiments with fluorescent probes for organelle damage showed that both 2-Pd and 2-Zn caused damage to both lysosomes and mitochondria, and although 2-Pd may have been somewhat more mitochondrial than 2-Zn, this would not seem to explain the large difference in potency.

The increase in the triplet yield from 0.8 to ~1 on moving from zinc to palladium does not seem to be a sufficient difference to account for the large differences in photodynamic efficiency. We initially employed the general probe for ROS, DCDHF as a means of confirming that the non-fluorescent 2-Pd was actually taken up into cells, and then tested the novel specific probe for hydroxyl radicals, HPF. This probe has been reported to be activated only by hydroxyl radicals, and not by singlet oxygen, hydrogen peroxide, superoxide, or lipid peroxides [36]. HPF was recently employed to demonstrate that bactericidal antibiotics exert their cytotoxic effect via generation of hydroxyl radicals [48]. We found out that the Pd porphyrin (2-Pd) produces more hydroxyl radicals than the Zn porphyrins (2-Zn and 1-Zn) when illuminated inside cells as well as in homogeneous solution. Moreover this effect can be quenched by the hydroxyl-radical quencher, mannitol. These findings may suggest an explanation for the large difference in phototoxicity of the three porphyrins. Many reports have suggested that hydroxyl radicals can be produced during PDT, and that their production is highly toxic to cells. Photodynamically generated hydroxyl radicals have been reported after illumination of PS such as Photofrin II [37], hematoporphyrin monomethyl ether [38], meso-tetrakis[4-(carboxymethoxy)phenyl]porphyrin [49], zinc phthalocyanine [50], bacteriochlorophyll a [51], and hypocrellin B [52] among others. Nevertheless, despite these reports, singlet oxygen is accepted as the major mediator of toxicity in PDT [5356].

There are three possible pathways by which hydroxyl radicals can be formed during PDT. These pathways all derive from Type I photochemistry (electron transfer) rather than Type II photochemistry (energy transfer). Firstly the PS excited triplet state can form a radical anion by accepting an electron from a biological reducing agent present inside cells such as NAD(P)H (eq 1). This radical anion can transfer an electron to molecular oxygen to form superoxide radical anion (eq 2). Superoxide can dismute to hydrogen peroxide either catalyzed by superoxide dismutase or spontaneously (eq 3).




Hydrogen peroxide can undergo Fenton chemistry catalyzed by small concentrations of ferrous iron producing hydroxyl radicals by one-electron reduction of hydrogen peroxide (eq 4), and the oxidized ferric iron can then be reduced back to ferrous iron by superoxide (eq 5); the combination of two reactions is termed the iron catalyzed Haber-Weiss reaction [57].


Secondly superoxide can react with nitric oxide in a very fast reaction to produce peroxynitrite (eq 6). Peroxynitrite can give rise to hydroxyl radicals (eq 7), and its oxidative reactions are very similar to those of hydroxyl radicals [58].


The third possibility is a direct reaction between hydrogen peroxide and the PS radical anion to form hydroxyl radicals and hydroxide anion (eq 8). This is equivalent to the one-electron reduction of hydrogen peroxide mediated by Fe2+ discussed above, but instead the PS radical anion is the reducing agent.


Which of these mechanisms (or others) is the most important in the present situation could be investigated by studies using added ferrous iron and/or iron chelators or added nitric oxide and nitric oxide scavengers, and such studies are underway.

An explanation of why the 2-Pd porphyrin should produce more hydroxyl radical than the 2-Zn porphyrin may reside in the greater propensity of the former versus the latter as an electron-transfer acceptor. The average ~0.2 eV greater ease of reduction of palladium porphyrins compared to zinc porphyrins [59] is complemented by the ~0.2 V higher energy of the triplet excited state (T1) (Table 1), which should make the T1 state of 2-Pd a more potent electron acceptor (oxidant) than 2-Zn by ~0.4 V. Thus, the involvement of such a two-step mechanism using the porphyrin T1 state as an electron-transfer mediator could complement the modestly higher intersystem-crossing yield in enhancing PDT activity of 2-Pd versus the other sensitizers. The difference in PDT efficacy of 2-Pd could be further enhanced by the fact that palladium porphyrins do not coordinate axial ligands to the central metal ion nearly as effectively as zinc porphyrins [47]. Thus, more prolific ligation of 2-Zn, for example, to entities in the cellular environment may slow or limit diffusion to the desired locale compared to 2-Pd.

Another, related factor that could be important in determining the photochemical mechanism operating in these compounds is the overall molecular charge. The finding that the cationic 2-Zn produces more hydroxyl radicals than the anionic 1-Zn under the same conditions could imply that 2-Zn is a better electron acceptor than 1-Zn, because of positive charge. The determination of the difference in reduction potentials of the two zinc porphyrins in vitro, or extrapolating from redox properties in solution (in either aqueous or organic media), are both problematic. However, there are documented examples showing that porphyrins bearing cationic substituents are more easily reduced compared to analogues with anionic substituents [60]. However, such effects would be expected to depend on the extent of conjugation of the peripheral group and the porphyrin macrocycle. Calculations have suggested that the sign of a charge and its position with respect to a tetrapyrrole macrocycle influences redox properties [61]. In this regard, the ability of the chain terminated in the sulfobutyl versus ethyl groups of 1-Zn versus 2-Zn to adopt a conformation that places the negative charge close to or over the face of the macrocycle may influence the relative reduction potentials.

These collective characteristics suggest that 2-Pd could be more predisposed to accept an electron and engage in consequent Type I photochemistry compared to the other porphyrins studied here: a favorable triplet excited-state energy level (and yield), a favorable redox potential imparted by the metal ion, and potential favorable redox and other properties associated with overall positive charge on the compound. There are literature reports concerning the reactive oxygen species produced by the Pd-bacteriopheophorbide PS known as TOOKAD. The authors used various experiments and lines of reasoning to attribute the cytotoxic effect (after illumination with near-infrared light) to the primary formation of superoxide and secondary formation of hydroxyl radical produced from hydrogen peroxide reacting with the PS triplet [62].

In conclusion, we have demonstrated that varying the central metal atom in a series of cationic porphyrins makes a substantial difference in the phototoxicity and that these differences cannot be easily explained by differences in photophysics, cell uptake or subcellular localization. It is proposed that the explanation resides in the greater propensity of the palladium porphyrin to efficiently generate the highly toxic hydroxyl radical upon illumination, and that this particular ROS is more effective in killing cells than the more commonly studied ROS, singlet oxygen and superoxide.

Figure 7
Fluorescence micrographs of HeLa cells incubated with 5 µM 1-Zn, 2-Zn or 2-Pd and either 5 µg/mL of CM-H2DCFDA or 10 µM HPF. Cells were either illuminated or not with 5 J/cm2 of 405-nm laser light (DCDHF) or with 5 J/cm2 of white ...

Supplementary Material



Work at Wellman Center for Photomedicine was funded by NIH-CA/AI838801 to MRH. Work at NCSU was supported by NIH-GM36238 to JSL. HLK was funded by the Imaging Sciences Pathway training grant from the NIH (5T90 DA022871) at Washington University.


Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.


1. Mroz P, Tegos GP, Gali H, Wharton T, Sarna T, Hamblin MR. Photodynamic therapy with fullerenes. Photochem Photobiol Sci. 2007;6:1139–1149. [PMC free article] [PubMed]
2. Castano AP, Demidova TN, Hamblin MR. Mechanisms in photodynamic therapy: part one - photosensitizes, photochemistry and cellular localization. Photodiagn. Photodyn. Ther. 2004;1:279–293. [PMC free article] [PubMed]
3. Detty MR, Gibson SL, Wagner SJ. Current clinical and preclinical photosensitizers for use in photodynamic therapy. J. Med. Chem. 2004;47:3897–3915. [PubMed]
4. Boyle RW, Dolphin D. Structure and biodistribution relationships of photodynamic sensitizers. Photochem. Photobiol. 1996;64:469–485. [PubMed]
5. Mroz P, Pawlak A, Satti M, Lee H, Wharton T, Gali H, Sarna T, Hamblin MR. Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism. Free Radic. Biol. Med. 2007;43:711–719. [PMC free article] [PubMed]
6. Gomer CJ. What makes a good photosensitizer for photodynamic therapy? J. Photochem. Photobiol. B. 1988;1:376–378. [PubMed]
7. Peng TI, Chang CJ, Guo MJ, Wang YH, Yu JS, Wu HY, Jou MJ. Mitochondrion-targeted photosensitizer enhances the photodynamic effect-induced mitochondrial dysfunction and apoptosis. Ann. N. Y. Acad. Sci. 2005;1042:419–428. [PubMed]
8. Ball DJ, Mayhew S, Wood SR, Griffiths J, Vernon DI, Brown SB. A comparative study of the cellular uptake and photodynamic efficacy of three novel zinc phthalocyanines of differing charge. Photochem. Photobiol. 1999;69:390–396. [PubMed]
9. Hamblin MR, Hasan T. Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem. Photobiol. Sci. 2004;3:436–450. [PMC free article] [PubMed]
10. Rodal GH, Rodal SK, Moan J, Berg K. Liposome-bound Zn (II)-phthalocyanine. Mechanisms for cellular uptake and photosensitization. J. Photochem. Photobiol. B. 1998;45:150–159. [PubMed]
11. van Leengoed HL, van der Veen N, Versteeg AA, Ouellet R, van Lier JE, Star WM. In vivo fluorescence kinetics of phthalocyanines in a skin-fold observation chamber model: role of central metal ion and degree of sulfonation. Photochem. Photobiol. 1993;58:233–237. [PubMed]
12. He J, Larkin HE, Li YS, Rihter D, Zaidi SI, Rodgers MA, Mukhtar H, Kenney ME, Oleinick NL. The synthesis, photophysical and photobiological properties and in vitro structure-activity relationships of a set of silicon phthalocyanine PDT photosensitizers. Photochem. Photobiol. 1997;65:581–586. [PubMed]
13. Mang TS, Allison R, Hewson G, Snider W, Moskowitz R. A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)-induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer. Cancer J. Sci. Am. 1998;4:378–384. [PubMed]
14. Ciulla TA, Criswell MH, Snyder WJ, Small WT. Photodynamic therapy with PhotoPoint photosensitiser MV6401, indium chloride methyl pyropheophorbide, achieves selective closure of rat corneal neovascularisation and rabbit choriocapillaris. Br. J. Ophthalmol. 2005;89:113–119. [PMC free article] [PubMed]
15. Verigos K, Stripp DC, Mick R, Zhu TC, Whittington R, Smith D, Dimofte A, Finlay J, Busch TM, Tochner ZA, Malkowicz S, Glatstein E, Hahn SM. Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer. J. Environ. Pathol. Toxicol. Oncol. 2006;25:373–387. [PubMed]
16. Koudinova NV, Pinthus JH, Brandis A, Brenner O, Bendel P, Ramon J, Eshhar Z, Scherz A, Salomon Y. Photodynamic therapy with Pd-Bacteriopheophorbide (TOOKAD): successful in vivo treatment of human prostatic small cell carcinoma xenografts. Int. J. Cancer. 2003;104:782–789. [PubMed]
17. Berdugo M, Bejjani RA, Valamanesh F, Savoldelli M, Jeanny JC, Blanc D, Ficheux H, Scherz A, Salomon Y, BenEzra D, Behar-Cohen F. Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes. Invest. Ophthalmol. Vis. Sci. 2008;49:1633–1644. [PubMed]
18. Bhaumik J, Yao Z, Borbas KE, Taniguchi M, Lindsey JS. Masked imidazolyl-dipyrromethanes in the synthesis of imidazole-substituted porphyrins. J. Org. Chem. 2006;71:8807–8817. [PubMed]
19. Srinivasan N, Haney CA, Lindsey JS, Zhang W, Chait BT. Investigation of MALDI-TOF mass spectrometry of diverse synthetic metalloporphyrins, phthalocyanines, and multiporphyrin arrays. J. Porphyrins Phthalocyanines. 1999;3:283–291.
20. Whitten JP, Matthews DP, McCarthy JR. 2-(Trimethylsilyl)ethoxy]methyl (SEM) as a novel and effective imidazole and fused aromatic imidazole protecting group. J. Org. Chem. 1986;51:1891–1894.
21. Perry VP. Cultivation of large cultures of HeLa cells in horse serum. Science. 1955;121:805. [PubMed]
22. Brattain MG, Strobel-Stevens J, Fine D, Webb M, Sarrif AM. Establishment of mouse colonic carcinoma cell lines with different metastatic properties. Cancer Res. 1980;40:2142–2146. [PubMed]
23. He P, Ahn JC, Shin JI, Hwang HJ, Kang JW, Lee SJ, Chung PS. Enhanced apoptotic effect of combined modality of 9-hydroxypheophorbide alpha-mediated photodynamic therapy and carboplatin on AMC-HN-3 human head and neck cancer cells. Oncol Rep. 2009;21:329–334. [PubMed]
24. Lobner D. Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis? J Neurosci Methods. 2000;96:147–152. [PubMed]
25. Merlin JL, Azzi S, Lignon D, Ramacci C, Zeghari N, Guillemin F. MTT assays allow quick and reliable measurement of the response of human tumour cells to photodynamic therapy. Eur J Cancer. 1992;28A:1452–1458. [PubMed]
26. Hamblin MR, Miller JL, Ortel B. Scavenger-receptor targeted photodynamic therapy. Photochem. Photobiol. 2000;72:533–540. [PubMed]
27. Sapan CV, Lundblad RL, Price NC. Colorimetric protein assay techniques. Biotechnol. Appl. Biochem. 1999;29(Pt 2):99–108. [PubMed]
28. Gronda M, Brandwein J, Minden MD, Pond GR, Schuh AC, Wells RA, Messner H, Chun K, Schimmer AD. Assessment of the downstream portion of the mitochondrial pathway of caspase activation in patients with acute myeloid leukemia. Apoptosis. 2005;10:1285–1294. [PubMed]
29. Sane AT, Bertrand R. Distinct steps in DNA fragmentation pathway during camptothecin-induced apoptosis involved caspase-, benzyloxycarbonyl-and N-tosyl-L-phenylalanylchloromethyl ketone-sensitive activities. Cancer Res. 1998;58:3066–3072. [PubMed]
30. Kessel D, Luo Y, Deng Y, Chang CK. The role of subcellular localization in initiation of apoptosis by photodynamic therapy. Photochem Photobiol. 1997;65:422–426. [PMC free article] [PubMed]
31. Marchesi E, Rota C, Fann YC, Chignell CF, Mason RP. Photoreduction of the fluorescent dye 2′-7′-dichlorofluorescein: a spin trapping and direct electron spin resonance study with implications for oxidative stress measurements. Free Radic Biol Med. 1999;26:148–161. [PubMed]
32. Kee HL, Bhaumik J, Diers JR, Mroz P, Hamblin MR, Bocian DF, Lindsey JS, Holten D. Photophysical characterization of imidazolium-substituted Pd(II), In(III), and Zn(II) porphyrins as photosensitizers for photodynamic therapy. J. Photochem. Photobiol. A. 2008;200:346–355. [PMC free article] [PubMed]
33. Redmond RW, Gamlin JN. A compilation of singlet oxygen yields from biologically relevant molecules. Photochem. Photobiol. 1999;70:391–475. [PubMed]
34. Luo Y, Kessel D. Initiation of apoptosis versus necrosis by photodynamic therapy with chloroaluminum phthalocyanine. Photochem Photobiol. 1997;66:479–483. [PubMed]
35. Antunes F, Cadenas E, Brunk UT. Apoptosis induced by exposure to a low steady-state concentration of H2O2 is a consequence of lysosomal rupture. Biochem J. 2001;356:549–555. [PubMed]
36. Setsukinai K, Urano Y, Kakinuma K, Majima HJ, Nagano T. Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species. J. Biol. Chem. 2003;278:3170–3175. [PubMed]
37. Athar M, Mukhtar H, Bickers DR. Differential role of reactive oxygen intermediates in photofrin-I-and photofrin-II-mediated photoenhancement of lipid peroxidation in epidermal microsomal membranes. J. Invest. Dermatol. 1988;90:652–657. [PubMed]
38. Ding X, Xu Q, Liu F, Zhou P, Gu Y, Zeng J, An J, Dai W, Li X. Hematoporphyrin monomethyl ether photodynamic damage on HeLa cells by means of reactive oxygen species production and cytosolic free calcium concentration elevation. Cancer Lett. 2004;216:43–54. [PubMed]
39. Milanesio ME, Alvarez MG, Silber JJ, Rivarola V, Durantini EN. Photodynamic activity of monocationic and non-charged methoxyphenylporphyrin derivatives in homogeneous and biological media. Photochem. Photobiol. Sci. 2003;2:926–933. [PubMed]
40. Kolarova H, Bajgar R, Tomankova K, Nevrelova P, Mosinger J. Comparison of sensitizers by detecting reactive oxygen species after photodynamic reaction in vitro, Toxicol. Vitro. 2007;21:1287–1291. [PubMed]
41. Rosenfeld A, Morgan J, Goswami LN, Ohulchanskyy T, Zheng X, Prasad PN, Oseroff A, Pandey RK. Photosensitizers derived from 13(2)-oxo-methyl pyropheophorbide-a: Enhanced effect of indium(III) as a central metal in in vitro and in vivo photosensitizing fficacy. Photochem Photobiol. 2006;82:626–634. [PubMed]
42. Gijsens A, Derycke A, Missiaen L, De Vos D, Huwyler J, Eberle A, de Witte P. Targeting of the photocytotoxic compound AlPcS4 to Hela cells by transferring conjugated PEG-liposomes. Int. J. Cancer. 2002;101:78–85. [PubMed]
43. van Nostrum CF. Delivery of photosensitizers in photodynamic therapy. Adv. Drug Deliv. Rev. 2004;56:5–6. [PubMed]
44. Margaron P, Gregoire MJ, Scasnar V, Ali H, van Lier JE. Structure-photodynamic activity relationships of a series of 4-substituted zinc phthalocyanines. Photochem. Photobiol. 1996;63:217–223. [PubMed]
45. Dummin H, Cernay T, Zimmermann HW. Selective photosensitization of mitochondria in HeLa cells by cationic Zn (II) phthalocyanines with lipophilic side-chains. J. Photochem. Photobiol. B. 1997;37:219–229. [PubMed]
46. MacDonald IJ, Morgan J, Bellnier DA, Paszkiewicz GM, Whitaker JE, Litchfield DJ, Dougherty TJ. Subcellular localization patterns and their relationship to photodynamic activity of pyropheophorbide-a derivatives. Photochem. Photobiol. 1999;70:789–797. [PubMed]
47. Kee HL, Bhaumik J, Diers JR, Mroz P, Hamblin MR, Bocian DF, Lindsey JS, Holten D. Photophysical characterization of imidazolium-substituted Pd(II), In(III), and Zn(II) porphyrins as photosensitizers for photodynamic therapy. J. Photochem. Photobiol. A. 2008 in press. [PMC free article] [PubMed]
48. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. A common mechanism of cellular death induced by bactericidal antibiotics. Cell. 2007;130:797–810. [PubMed]
49. Chatterjee SR, Possel H, Srivastava TS, Kamat JP, Wolf G, Devasagayam TP. Photodynamic effects induced by meso-tetrakis[4-(carboxymethyleneoxy)phenyl] porphyrin on isolated Sarcoma 180 ascites mitochondria. J. Photochem. Photobiol. B. 1999;50:79–87. [PubMed]
50. Hadjur C, Wagnieres G, Ihringer F, Monnier P, van den Bergh H. Production of the free radicals O2.-and .OH by irradiation of the photosensitizer zinc(II) phthalocyanine. J. Photochem. Photobiol. B. 1997;38:196–202. [PubMed]
51. Hoebeke M, Schuitmaker HJ, Jannink LE, Dubbelman TM, Jakobs A, Van de Vorst A. Electron spin resonance evidence of the generation of superoxide anion, hydroxyl radical and singlet oxygen during the photohemolysis of human erythrocytes with bacteriochlorin a. Photochem. Photobiol. 1997;66:502–508. [PubMed]
52. An H, Xie J, Zhao J, Li Z. Photogeneration of free radicals (*OH and HB*-) and singlet oxygen (1O2) by hypocrellin B in TX-100 micelles microsurroundings. Free Radic. Res. 2003;37:1107–1112. [PubMed]
53. Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res. 1976;36:2326–2329. [PubMed]
54. Clo E, Snyder JW, Ogilby PR, Gothelf KV. Control and selectivity of photosensitized singlet oxygen production: challenges in complex biological systems. Chembiochem. 2007;8:475–481. [PubMed]
55. Jarvi MT, Niedre MJ, Patterson MS, Wilson BC. Singlet oxygen luminescence dosimetry (SOLD) for photodynamic therapy: current status, challenges and future prospects. Photochem. Photobiol. 2006;82:1198–1210. [PubMed]
56. Moan J, Juzenas P. Singlet oxygen in photosensitization. J. Environ. Pathol. Toxicol. Oncol. 2006;25:29–50. [PubMed]
57. Koppenol WH. The Haber-Weiss cycle-70 years later. Redox Rep. 2001;6:229–234. [PubMed]
58. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U S A. 1990;87:1620–1624. [PubMed]
59. Felton RH. In: The Porphyrins. Dolphin D, editor. vol. V. New York: Academic Press; 1978. pp. 5–125.
60. Kalyanasundaram K, Beumann-Spallart M. Photophysical and redox propoerties of water-soluble porphyrins in aqueous media. J. Phys. Chem. 1982;86 8163-5169.
61. Hanson LK, Fajer J, Thompson MA, Zerner MC. Electrochromic effects of charge separation in bacterial photosynthesis: theoretical models. J. Am. Chem. Soc. 1987;109:4728–4730.
62. Vakrat-Haglili Y, Weiner L, Brumfeld V, Brandis A, Salomon Y, McLlroy B, Wilson BC, Pawlak A, Rozanowska M, Sarna T, Scherz A. The microenvironment effect on the generation of reactive oxygen species by Pd-bacteriopheophorbide. J. Am. Chem. Soc. 2005;127:6487–6497. [PubMed]